AIRS Medical is a pioneering healthcare AI company founded in 2018 in South Korea and has emerged as a leader in leveraging AI to revolutionize the healthcare industry. The company's mission, encapsulated in the slogan: "We break the rules and fix them through AI for a world without sickness. SwiftMR™, AI-Powered MRI Enhancement Solution," reflects their commitment to transforming the healthcare landscape through innovative technology.
With a focus on healthcare, AIRS Medical aims to make the medical sector more efficient and accessible, ultimately enabling a more patient-friendly healthcare system. Its recent Series B investment of KRW25.30B on 27 July 2022 from Klim Ventures, Hanwha Life, and Q Capital Partners emphasizes investors' confidence in the company's vision and technological capabilities.
AIRS Medical's approach to digital transformation within the healthcare domain is positioned to provide an unparalleled healthcare experience, marking the company as one to watch in the rapidly evolving field of healthcare AI.